Cautionary Tale for Japan M&A in Ranbaxy Fail - Presented by: The Aol. On Network

(SOUNDBITE) (English) REUTERS REPORTER, TARA JOSEPH, SAYING: "India's Sun Pharmaceuticals, Peter, buying Ranbaxy for 3.2 billion dollars. Now Ranbaxy has had trouble getting its drugs to market. But



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 114.531 3.91 ▼ 3.30%
S $ 3.465 0.13 ▲ 3.74%
BAX $ 40.745 1.24 ▲ 3.13%
BAC $ 17.76 0.01 ▼ 0.06%
BXLT $ 37.87 4.72 ▲ 14.24%
MGM $ 21.595 1.75 ▲ 8.79%
NFLX $ 121.37 8.81 ▲ 7.83%
FTR $ 5.20 0.05 ▲ 0.97%

As of 8/4/2015, 01:04 PM